Cargando…
C5 inhibition allows continued antineoplastic therapy in cancer- and chemotherapy-associated thrombotic microangiopathy
Autores principales: | Shah, Hridaya, Chen, Hang, Pan, Xiang-Zuo, Metjian, Ara, Brodsky, Robert A., Braunstein, Evan M., Chaturvedi, Shruti |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The American Society of Hematology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9713277/ https://www.ncbi.nlm.nih.gov/pubmed/35914225 http://dx.doi.org/10.1182/bloodadvances.2022008395 |
Ejemplares similares
-
SARS-CoV-2 vaccination and immune thrombotic thrombocytopenic purpura
por: Shah, Hridaya, et al.
Publicado: (2022) -
Chemotherapy-Associated Thrombotic Microangiopathy
por: Aklilu, Abinet M., et al.
Publicado: (2023) -
Eculizumab in chemotherapy-induced thrombotic microangiopathy
por: Schulte-Kemna, Lena, et al.
Publicado: (2020) -
Thrombotic Microangiopathies
por: Radhi, Mohamed, et al.
Publicado: (2012) -
The thrombotic microangiopathies
por: Copelovitch, Lawrence, et al.
Publicado: (2008)